antifungal/cáncer

El enlace se guarda en el portapapeles.

Elija el tipo de clasificación

Página 1 desde 6124 resultados

Therapeutic targets in cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

CROSS-REFERENCE TO RELATED APPLICATIONS This application is related to the following U.S. Applications: U.S. Ser. No. 10/034,650, filed Dec. 20, 2001; U.S. Ser. No. 10/035,832, filed Dec. 26, 2001; U.S. Ser. No. 10/004,113, filed Oct. 23, 2001; U.S. Ser. No. 09/997,722, filed Nov. 30, 2001; U.S.

Therapeutic targets in cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

CROSS-REFERENCE TO RELATED APPLICATIONS This application is related to the following U.S. applications: U.S. Ser. No. 10/034,650, filed Dec. 20, 2001; U.S. Ser. No. 10/035,832, filed Dec. 26, 2001; U.S. Ser. No. 10/004,113, filed Oct. 23, 2001; U.S. Ser. No. 09/997,722, filed Nov. 30, 2001; U.S.

Salmonella cancer therapeutics and related therapeutic methods

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION The use of bacteria to treat cancer has been investigated for well over 150 years, and many genera of bacteria, including Clostridium, Bifidus, and Salmonella, have been shown to preferentially accumulate in tumor tissue and cause regression. The efficacy of such standard

Systems and methods for providing dynamic, individualized digital therapeutics for cancer prevention, detection, treatment, and survivorship

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

TECHNICAL FIELD This document generally relates to computing techniques that can be used to efficiently provide digital therapeutics and precision medicine. BACKGROUND Due to the effectiveness of modern cancer treatment, patients are surviving cancer at higher rates and with longer expected

NEAT1 as a prognostic marker and therapeutic target for prostate cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

INCORPORATION BY REFERENCE OF SEQUENCE LISTING The Sequence Listing in an ASCII text file, named 31008--6063--03--US--Sequence Listing.txt of 44 KB, created on Oct. 13, 2016 , and submitted to the United States Patent and Trademark Office via EFS-Web, is incorporated herein by reference. FIELD OF

Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND The membrane type (MT)-matrix metalloproteinases (MMPs) constitute a sub-group of membrane-anchored MMPs that are major mediators of pericellular proteolysis and physiological activators of pro-MMP-2. MT-MMPs activate the zymogenic form of MMP-2 (pro-MMP-2 or pro-gelatinase A). MMP-2, in

Method and kit for predicting the therapeutic response of a drug against a malignant tumor

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

The present invention relates generally to a method of predicting the therapeutic response of a drug. More specifically, the invention relates to a method of predicting the therapeutic response of a drug directed towards a malignant tumour in a human patient, and to a diagnostic kit in order to

Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

SEQUENCE LISTING The instant application contains a Sequence Listing, which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Nov. 30, 2012, is named 1379448102.txt and is 31,008 bytes in size. TECHNICAL FIELD OF THE

Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND (a) Field The subject matter disclosed generally relates to methods of inhibiting cancer tumor growth in a patient in need thereof. More specifically, the subject matter disclosed relates to methods of inhibiting cancer tumor growth in a patient by administering a first treatment

Therapeutic implications of dickkopf affecting cancer stem cell fate

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

This Application claims benefit of U.S. Provisional Patent Application Ser. No. 61/159,123 filed Mar. 11, 2009, the contents of which are incorporated herein by reference. A. TECHNICAL FIELD Breast cancer is the most prevalent cancer among women worldwide and current therapies still fall short of

Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION 1. Field of the Invention The field of this invention is identifying, treating and monitoring patients having breast cancer or patients at risk of getting breast cancer. 2. Description of the Background Art Estrogen activity has an established relationship to breast

Neuregulin-1-based prognosis and therapeutic stratification of colorectal cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national stage entry under 35 U.S.C. .sctn.371 of PCT International Patent Application No. PCT/EP2012/67758, filed Sep. 12, 2012, which claims priority to European Patent Application No. 11180878.8, filed Sep. 12, 2011, the contents

HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION Cancer causes one in every four US deaths and is the second leading cause of death among Americans. Among cancers, breast cancer represents the most common form of cancer among women. Each year, more than 180,000 and 1 million women in the U.S. and worldwide,

Cadherin-17 as diagnostic marker and therapeutic target for liver cancer

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

FIELD OF THE INVENTION This invention relates to compositions and methods for detecting and inhibiting cancer by targeting the expression, translation, and biological activity of liver-intestine cadherin (LI-cadherin), CDH17. BACKGROUND OF THE INVENTION Hepatocellular carcinoma (HCC), commonly

Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

The present invention relates to the cancerology field. More particularly, the present invention relates to a method for diagnosing cancer, and more particularly breast, thyroid, lung or prostate cancer, in a human patient by in vitro determination of the presence of the nerve growth factor

Únete a nuestra
página de facebook

Herbal & Natural Medicine

La base de datos de hierbas medicinales más completa respaldada por la ciencia

Funciona en 55 idiomas
Curas a base de hierbas respaldadas por la ciencia
Reconocimiento de hierbas por imagen
Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
Leer publicaciones científicas relacionadas con su búsqueda
Buscar hierbas medicinales por sus efectos.
Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.